Psychiatric Genomics, Inc.

Dr. C. Anthony Altar is President and Chief Scientific Officer at Psychiatric Genomics. His research team is responsible for gene discovery, medicinal chemistry, and drug discovery efforts. Dr. Altar has published 120 articles in peer-reviewed journals that include Science, Nature, PNAS, and the Burger’s Medicinal Chemistry series. He pioneered methods for receptor localization using computerized image analysis and discovered the serotonin/ dopamine receptor binding patterns of antipsychotic drugs, which typify the atypical antipsychotics now in use. His team at Regeneron identified brain actions of neurotrophic factors, including roles in human depression, now an experimental clinical approach. As Director for Global Neuroscience Research at Otsuka America Pharmaceuticals, Dr. Altar led the team that discovered and co-developed aripiprazole (Abilify), recently FDA-approved.

Contact Details: 19 Firstfield Rd. Gaithersburg Maryland 20878 United States of America Tel: 301.556.1300 Fax: 301.556.1350 Email: mail@psygenomics.com WWW: www.psygenomics.com/

Loading...

Psychiatric Genomics, Inc. Patents:
US Patent No.	Title
7132287	Method for neural stem cell differentiation using 5HT-1A agonists
7132286	Method for neural stem cell differentiation using valproate

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 1038 times since April 2007, the link to the organisation's website has been followed 231 times

Recent Search Terms used to find this page: Psychiatric Genomics, Inc. fax | Psychiatric Genomics | t | Psychiatric Genomics | t | Psychiatric Genomics Inc | t | t | t | Psychiatric Genomics Inc. | .

Search for more companies in Gaithersburg

Search for more companies in Maryland

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Psychiatric Genomics, Inc.